Đang chuẩn bị liên kết để tải về tài liệu:
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Patients with malignant mesothelioma have a poor prognosis and only 40% respond to first line treatment; a combination of pemetrexed and cisplatin or carboplatin. We used primary malignant mesothelioma cells and an ex vivo chemosensitivity assay with future purpose to predict best choice of treatment. |